Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners?

International Journal of Cardiology

Volumn 59, Issue 1, 1997, Pages 7-10

  Houghton, Andrew R ^a   Cowley, A J ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Adverse effects; Angiotensin converting enzyme inhibitor; General practice; Heart failure

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; DRUG USE; GENERAL PRACTITIONER; HEART FAILURE; HUMAN; HYPOTENSION; KIDNEY FAILURE; PRIORITY JOURNAL; QUESTIONNAIRE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ATTITUDE OF HEALTH PERSONNEL; DRUG UTILIZATION; HEALTH CARE SURVEYS; HEART FAILURE, CONGESTIVE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; QUESTIONNAIRES;

EID: 0030990965     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(96)02904-X     Document Type: Article

References (13)

1. Wheeldon NM, MacDonald TM, Flucker CJ, McKendrick AD, McDevitt DO, Struthers AD. Echocardiography in chronic heart failure in the community. Q J Med 1993;86:17-23.
2. Clarke KW, Gray D, Hampton JR. The prevalence of heart failure estimated from prescription data. Br Heart J 1994;71 (Suppl):P33.
3. McMurray J, McDonagh T, Morrison CE, Dargie HJ. Trends in hospitalization for heart failure in Scotland 1980-1990. Eur Heart J 1993;14:1158-1162.
4. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971;285:1441-1446.
5. McMurray J, Hart W, Rhodes G. An evaluation of the cost of heart failure to the National Health Service in the UK. Br J Med Economics 1993;6:99-110.
6. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-1435.
7. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive failure. N Engl J Med 1991;325:293-302.
8. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303-310.
9. Hart W, Rhodes G, McMurray J. The cost effectiveness of enalapril in the treatment of chronic heart failure. Br J Med Economics 1993;6:91-98.
10. Clarke KW, Gray D, Hampton JR. Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J 1994;71:584-587.
11. Mair FS, Crowley TS, Bundred PE. Prevalence, aetiology and management of heart failure in general practice. Br J Gen Pract 1996;46:77-79.
12. Andrews R, Cowley AJ. Clinical and economic factors in the treatment of congestive heart failure. Pharmacoeconomics 1995;7:119-127.
13. Hood WB, Youngblood M, Ghali JK et al. for the SOLVD investigators. Initial blood pressure response to enalapril in hospitalized patients (Studies of Left Ventricular Dysfunction [SOLVD]). Am J Cardiol 1991;68:1465-1468.